Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1983 1
1986 1
1988 1
1989 2
1990 1
1991 4
1992 1
1993 4
1994 1
1995 4
1996 3
1997 7
1998 12
1999 16
2000 16
2001 21
2002 18
2003 19
2004 20
2005 5
2006 7
2007 7
2008 6
2009 10
2010 8
2011 11
2012 10
2013 12
2014 4
2015 5
2016 7
2017 10
2018 35
2019 63
2020 53
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 15060258

377 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P. Milgrom H, et al. Pediatrics. 2001 Aug;108(2):E36. doi: 10.1542/peds.108.2.e36. Pediatrics. 2001. PMID: 11483846 Clinical Trial.
Omalizumab for asthma in adults and children.
Normansell R, Walker S, Milan SJ, Walters EH, Nair P. Normansell R, et al. Cochrane Database Syst Rev. 2014 Jan 13;(1):CD003559. doi: 10.1002/14651858.CD003559.pub4. Cochrane Database Syst Rev. 2014. PMID: 24414989 Review.
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.
Solèr M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, Thirlwell J, Gupta N, Della Cioppa G. Solèr M, et al. Eur Respir J. 2001 Aug;18(2):254-61. doi: 10.1183/09031936.01.00092101. Eur Respir J. 2001. PMID: 11529281 Free article. Clinical Trial.
Omalizumab is effective in the long-term control of severe allergic asthma.
Lanier BQ, Corren J, Lumry W, Liu J, Fowler-Taylor A, Gupta N. Lanier BQ, et al. Ann Allergy Asthma Immunol. 2003 Aug;91(2):154-9. doi: 10.1016/S1081-1206(10)62170-9. Ann Allergy Asthma Immunol. 2003. PMID: 12952109 Clinical Trial.
The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma.
Buhl R, Hanf G, Solèr M, Bensch G, Wolfe J, Everhard F, Champain K, Fox H, Thirlwell J. Buhl R, et al. Eur Respir J. 2002 Nov;20(5):1088-94. doi: 10.1183/09031936.02.00016502. Eur Respir J. 2002. PMID: 12449159 Free article. Clinical Trial.
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma.
Buhl R, Solèr M, Matz J, Townley R, O'Brien J, Noga O, Champain K, Fox H, Thirlwell J, Della Cioppa G. Buhl R, et al. Eur Respir J. 2002 Jul;20(1):73-8. doi: 10.1183/09031936.02.00278102. Eur Respir J. 2002. PMID: 12166585 Free article. Clinical Trial.
377 results
Jump to page
Feedback